GAVI’s Investment in the Six-in-One Vaccine and Future Plans for Global Health

Looking ahead, the organization recognized the growing threat of climate change and outbreaks with epidemic potential.

Photo: The Spectator – Gustavo Torrijos Zuluaga

The Alliance for Vaccination, known as GAVI, an association that seeks to improve access to vaccines in developing countries, approved at the last meeting of its board the investment in the six-in-one vaccine: a combination of the pentavalent vaccine, which protects against diphtheria, tetanus, pertussis (whooping cough), hepatitis B and Haemophilus influenzae type b, and inactivated polio vaccine. It is, then, a single injection that can protect against 6 diseases.

You can see: 91% of the Colombian population believes that motherhood should not be forced

This decision opens a window for countries, especially the poorest ones, to request financing. “With over a billion unique children cared for, one eighth of humanity has now been protected by the Vaccine Alliance. While it is crucial to recognize past achievements, the continuing measure of success will be how we build on these experiences to deliver even more impact in the future,” said Seth Berkley, CEO of Gavi.

The Gavi Board also confirmed that it will continue to support countries in their efforts to ensure high-risk groups are protected against Covid-19 in 2024-2025 and that it will restart programs to introduce vaccines that were previously approved but stopped. due to the pandemic or development delays. Some of them are hepatitis B birth dose, diphtheria, tetanus and pertussis boosters and rabies post-exposure prophylaxis (PEP).

You can see: Science goes one step further to reveal some mysteries of multiple sclerosis

Looking ahead, the organization recognized the growing threat of climate change and outbreaks with epidemic potential, and that vaccines have played a central role in all public health emergencies of international concern. For this reason, in addition, Gavi will seek to invest in the research of candidate vaccines against Marburg and Ebola. “This week’s decisions by the Board provide us with a clear path toward an Alliance that is even more effective in protecting lives, addressing the consequences of climate change, and harnessing innovation to support countries,” the Berkley concluded.

2023-07-01 13:20:00
#sixinone #vaccine #reach #poorest #countries #world